About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT05168982

Development of Non-Invasive MRI Applications for Liver Fibrosis and Inflammation

Chronic liver disease is a major healthcare problem in Hong Kong and worldwide. The diagnosis of liver fibrosis and inflammation in patients with chronic liver disease has important prognostic and the...

Lead sponsor: Chinese University of Hong Kong•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Chinese University of Hong Kong

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Between the age of 18 and 65.
•Chronic liver disease (CLD) patients at different stages of liver inflammation (A0-3) and liver fibrosis (F0-4).
•CLD patients who have indications and are scheduled to undergo liver biopsy.

Exclusion Criteria

•Patients diagnosed with HCC or other types of cancers.
•Patients who had undergone liver transplantation before enrollment.
•Any contraindications to either liver biopsy or MRI scan.

Related studies

RECRUITINGPhase 1

The Phase 1, Open-label, PET Trial Designed to Investigate the Effect of AZD2389 on FAP Occupancy in the Liver in Participants With Advanced Liver Fibrosis.

NCT07069725 · Liver Fibrosis, Hepatic Cirrhosis

RECRUITINGPhase 2

A Study of Hydronidone Capsules in Patients With Chronic Hepatitis B Virus-Related Liver Fibrosis

NCT07417553 · Chronic Hepatitis B-related Liver Fibrosis

Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease

NCT07265544 · Liver Neoplasm, HBV Infection, and more

Rapid Breath-hold Quantitative Macromolecular Proton Fraction Imaging for Liver Fibrosis

NCT04429100 · Liver Fibrosis

RECRUITINGPhase 3

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

NCT06632444 · Metabolic Dysfunction Associated Steatohepatitis (MASH), Liver Fibrosis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 19, 2026Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment200

Start dateAug 2021

Last updatedMar 19, 2026

Condition

Locations shown

The Chinese University of Hong Kong, Prince of Wale Hospital

Hong Kong, Shatin

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 19, 2026Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions